Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.2B | 7.9B | 9.0B | 7.9B |
Cost of revenue | 5.8B | 6.6B | 6.4B | 6.3B |
Gross profit | 1.3B | 1.2B | 2.6B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 284M | 250M | 257M | 275M |
Other operating expenses | 848M | 616M | 586M | 352M |
Operating income | -342M | 396M | 1.2B | 501M |
Non operating interest income | ||||
Income | 31M | 67M | 34M | 39M |
Expense | 222M | 160M | 211M | 189M |
Other income expense | — | — | — | — |
Pretax income | -334M | -86M | 1.1B | 215M |
Tax provision | -103M | -97M | 300M | 49M |
Net income | -249M | -21M | 824M | 166M |
Basic EPS | — | -0.2 | — | — |
Diluted EPS | — | -0.2 | — | — |
Basic average shares | — | 262.7M | — | — |
Diluted average shares | — | 262.7M | — | — |
EBITDA | 616M | 847M | 2.0B | 1.0B |
Net income from continuing op. | -249M | -21M | 824M | 166M |
Minority interests | -43M | -42M | -44M | -44M |
Preferred stock dividends | 13M | 0 | 15M | 14M |